Background: Up to 70% of children with small bowel transplantation (SBTx) experience acute cellular rejection (ACR). Allospecific CD154+ T cells predict liver ACR in children in a novel, 16-hour mixed leukocyte response (MLR) assay, but remain untested in SBTx.
Methods: The expression of CD154 was measured in 4 subsets-naive (N) and memory (M) CD154+ T-helper (Th) and T-cytotoxic (Tc) cells (ie, CD154+ ThN, CD154+ ThM, CD154+ TcN, and CD154+ TcM, respectively)-in the MLR of single blood samples obtained from 32 children with SBTx within 60 days of SBTx biopsy. Children showing ACR in these biopsies were termed Rejectors. The ratio of donor-induced to third-party-induced CD154+ T cells was called the immunoreactivity index (IR). We hypothesized that IR >1 denoted increased donor-specific alloreactivity and increased risk of rejection; in contrast, IR <1 implied decreased risk. CD154 expression was correlated with the expression of CTLA4, a negative T-cell costimulator that antagonizes and is inversely related to CD154 (n = 18).
Results: Rejectors showed significantly greater numbers of donor-specific CD154+ T-cell subsets. Logistic regression analysis and leave-one-out cross validation followed by receiver operating characteristic analysis showed that, among the 4 subsets, IR > or =1.23 for CD154+ TcM identified Rejectors with a sensitivity and specificity of 93% and 88%. Also, a significant negative correlation was observed between CD154 expression and CTLA4 expression in allospecific Tc (Spearman's rho = -0.616, P = .006) but not in Th.
Conclusion: Allospecific CD154+ TcM identify rejection-prone children with SBTx.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.surg.2009.04.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Extracellular Vesicle-associated GARP/TGFβ:LAP Mediates "Infectious" Allo-tolerance.
Transplant Direct
June 2023
Division of Transplantation, Department of Surgery, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI.
Unlabelled: Here we test the hypothesis that, like CD81-associated "latent" IL35, the transforming growth factor (TGF)β:latency-associated peptide (LAP)/glycoprotein A repetitions predominant (GARP) complex was also tethered to small extracellular vesicles (sEVs), aka exosomes, produced by lymphocytes from allo-tolerized mice. Once these sEVs are taken up by conventional T cells, we also test whether TGFβ could be activated suppressing the local immune response.
Methods: C57BL/6 mice were tolerized by i.
Development of a humanized mouse model to analyze antibodies specific for human leukocyte antigen (HLA).
PLoS One
July 2021
Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
In organ transplantation, human leukocyte antigen (HLA)-mismatch grafts not only induce the activation of cellular mediated immune response but also the development of chronic antibody-mediated rejection due to the donor-specific anti-HLA antibody (DSA) produced by B cells and plasma cells interacting with the graft endothelium. Significant improvement in long-term survival after transplantation can be expected if antibody-mediated rejection due to the DSA can be overcome. However, the mechanism of producing or controlling the DSA remains to be elucidated.
View Article and Find Full Text PDFRenal allograft surveillance with allospecific T-cytotoxic memory cells.
Ren Fail
November 2020
Department of Surgery, Division of Transplant Surgery, Medical University of South Carolina, Charleston, SC, USA.
Background: Allo-antigen-specific T-cytotoxic memory cells (TcM) which express CD40 ligand (CD154) in overnight lymphocyte co-culture are strongly associated with acute cellular rejection (ACR) seen in "for cause" biopsies for renal allograft dysfunction. Specifically, when the likelihood of rejection is increased, donor-specific allospecific TcM exceed those induced by HLA-non-identical third-party cell by 1.15-fold or greater.
View Article and Find Full Text PDFBiomarkers of rejection in kidney transplantation.
Curr Opin Organ Transplant
February 2019
Division of Nephrology, Department of Internal Medicine, Henry Ford Health System, Detroit, Michigan, USA.
Purpose Of Review: To provide an update of the literature on the use of new biomarkers of rejection in kidney transplant recipients.
Recent Findings: The kidney allograft biopsy is currently considered the gold standard for the diagnosis of rejection. However, the kidney biopsy is invasive and could be indeterminate.
Donor bone marrow cells are essential for iNKT cell-mediated Foxp3+ Treg cell expansion in a murine model of transplantation tolerance.
Eur J Immunol
April 2017
Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
Article Synopsis
- Mixed chimerism induction is an effective method for achieving transplantation tolerance, utilizing a unique treatment with anti-CD40L and a specialized ligand after transferring donor bone marrow cells (BMCs) to sub-lethally irradiated mice.
- This treatment led to an increase in regulatory T (Treg) cells and mixed chimerism, but the exact mechanisms driving Treg cell expansion and function were not fully understood.
- The study found that replacing BMCs with spleen cells did not achieve the desired immune effects, indicating that donor BMCs play a crucial role in expanding bioactive Treg cells necessary for prolonged graft survival.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!